Allograft Arteriosclerosis and Immune-Driven Angiogenesis
- 11 March 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (9) , 1237-1239
- https://doi.org/10.1161/01.cir.0000059744.64373.08
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Angiopoietin-1 Protects Against the Development of Cardiac Allograft ArteriosclerosisCirculation, 2003
- Vascular Endothelial Growth Factor Enhances Cardiac Allograft ArteriosclerosisCirculation, 2002
- Host CD40 Ligand Deficiency Induces Long-Term Allograft Survival and Donor-Specific Tolerance in Mouse Cardiac Transplantation But Does Not Prevent Graft ArteriosclerosisThe Journal of Immunology, 2000
- Simvastatin Reduces Graft Vessel Disease and Mortality After Heart TransplantationCirculation, 1997
- Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts.Journal of Clinical Investigation, 1997
- Immunologic basis of transplant-associated arteriosclerosis.Proceedings of the National Academy of Sciences, 1996
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T cells requires contact-dependent interactions involving CD2 but not CD28.The Journal of Immunology, 1994
- Concurrent Overproduction of Synapses in Diverse Regions of the Primate Cerebral CortexScience, 1986
- Hyperlipidemia and AtherosclerosisScience, 1976